COVID-19: Vaccine Information for Providers

Recent News (January 22-30)

Webinars

Upcoming

Date/Time: Friday, February 5, at 1 p.m.
Registration: Register through WebEx

Recent

More Information on Vaccines



See guidance below for providers about COVID-19, including how you can get vaccinated.

Find a Vaccination Site and Make an Appointment

Health care workers, other essential workers and several other groups of people are currently eligible to receive a vaccine.

  • COVID-19 Vaccine Finder: If you are eligible to receive a vaccine, find a location and learn how to schedule an appointment (not accessible with Internet Explorer).
  • You can also schedule an appointment by calling 877-VAX-4NYC (877-829-4692).
  • New York State COVID-19 Vaccine Form: Form required to complete before you get vaccinated.

Vaccine Communication and Encouragement

Talking to Health Care Staff

Talking to Patients

Direct your patients to the COVID-19: Vaccine Eligibility page so they can stay up to date on who is eligible for the vaccine. Begin talking with them now about the benefits and risks of the COVID-19 vaccine.

Information for Patients

Outreach

General FAQs and Resources

Vaccine Benefits

Science

After Vaccination

Register to Provide Vaccinations

Become a Vaccine Provider

NYC providers who want to participate in the city's COVID-19 vaccine program will need to enroll with the Citywide Immunization Registry (CIR). They must use the CIR to electronically sign a provider agreement, place their order and report all doses administered.

Order Vaccine Doses

Once your Provider Agreement is approved by the NYC Health Department (and if you have appropriate vaccine storage), you will receive instructions on how to order vaccine doses through the CIR.

You will be notified when supply increases and doses have been allocated to you. Vaccine will be shipped directly to your facility from the manufacturer or the CDC’s distribution center.

Due to the limited supply of vaccine, the specific vaccine available will be determined by manufacturer supply, vaccination site and vaccine allocation.

Billing

You must offer the COVID-19 vaccine to all eligible people, regardless of insurance status or ability to pay.

You may not bill for the cost of the vaccine, but you are permitted to bill the recipient’s health insurance plan for an administration fee. If a recipient does not have health insurance, or if their insurance does not cover the administration fee, you can request reimbursement for the administration of the COVID-19 vaccine through the Provider Relief Fund.

Pharmacies

Vaccinating Nursing Home or Assisted Living Facility Residents

Storage and Administration

Fact Sheets for Vaccine Providers

Fact Sheets for Recipients

You are required to give information consistent with these fact sheets to patients before they receive the respective vaccines.

Other Patient Handouts

Pre-Vaccination Screening

Vaccine Storage

Administration Standing Orders

How to Administer

Post-Injection Observation

You should observe the following groups of people for 30 minutes after vaccinating:

  • People with a history of an immediate allergic reaction of any severity to a vaccine or injectable therapy
  • People with a history of anaphylaxis due to any cause

Observe all other people for 15 minutes after injection.

Reporting

You must report each vaccine administration to both of the systems listed below. Patient consent is not required.

For information on reporting an adverse event in VAERS, see the Adverse Events Reporting section.

Physical Space and Workflow

An effective COVID-19 vaccination program may require changes to your scheduling, waiting room and patient flow.

Waiting Room

  • Determine if there are other areas where patients can wait if waiting room capacity is limited.
  • Plan for accommodations in case of inclement weather, when waiting outdoors is not possible.

Monitoring for Side Effects

  • Review CDC guidance on preparing for anaphylaxis.
  • Determine where patients can be safely monitored while still maintaining social distance, such as an exam room or observation area.
  • If you monitor patients in the exam room, allow time in your schedule for observation and managing exam room use.

Temporary Locations

Clinical Considerations for Vaccines

General Clinical Considerations for Available Vaccines

Post-Vaccination Symptoms

Product-Specific Information

Advisory Committee on Immunization Practices (ACIP) Guidance

Journal Articles

Safety, Contraindications and Precautions

Adverse Events Reporting

Certain adverse events must be reported to the Vaccine Adverse Event Reporting System (VAERS).

Best Practices and Quality Improvement

Resources including best practices to maximize efficacy and efficiency of your program.

Vaccine Approval Process

The below resources outline the process for COVID-19 vaccine development, from research to clinical trials to Emergency Use Authorization (EUA).

FDA Reviews

Advisory Committee on COVID-19 (ACIP)

Data on Vaccines

The following resources show data on vaccine allocation, distribution and administration.

Trainings and Webinars

Training Modules on COVID-19 Vaccines

Webinars

Past webinar videos and slides are provided here for reference. They may not contain the most up-to-date information.

2021

2020

Additional Resources